Journal of Biological Chemistry
Volume 277, Issue 47, 22 November 2002, Pages 44695-44700
Journal home page for Journal of Biological Chemistry

MECHANISMS OF SIGNAL TRANSDUCTION
Ligand-independent trans-Activation of the Platelet-derived Growth Factor Receptor by Reactive Oxygen Species Requires Protein Kinase C-δ and c-Src*

https://doi.org/10.1074/jbc.M208332200Get rights and content
Under a Creative Commons license
open access

Reactive oxygen species are involved in the mitogenic signal transduction cascades initiated by several growth factors and play a critical role in mediating cardiovascular diseases. Interestingly, H2O2 induces tyrosine phosphorylation and trans-activation of the platelet-derived growth factor receptor and the epidermal growth factor receptor in many cell lines including vascular smooth muscle cells. To investigate the molecular mechanism by which reactive oxygen species contribute to vascular diseases, we have examined a signal transduction cascade involved in H2O2-induced platelet-derived growth factor receptor activation in vascular smooth muscle cells. We found that H2O2 induced a ligand-independent phosphorylation of the platelet-derived growth factor-β receptor at Tyr1021, a phospholipase C-γ binding site, involving the requirement of protein kinase C-δ and c-Src that is distinct from a ligand-dependent autophosphorylation. Also, H2O2 induced the association of protein kinase C-δ with the platelet-derived growth factor-β receptor and c-Src in vascular smooth muscle cells. These findings will provide new mechanistic insights by which enhanced reactive oxygen species production in vascular smooth muscle cells induces unique alleys of signal transduction distinct from those induced by endogenous ligands leading to an abnormal vascular remodeling process.

Cited by (0)

*

This work was supported by National Institute of Health Training Grant HL-07323 and a United Negro College Fund/Merck Postdoctoral Science Research Fellowship (to G. D. F.) and in part by the Research Grants HL58205, CA68485, and DK20593 from the National Institutes of Health, an American Heart Association scientist development grant (to S. E.), and Vanderbilt University Diabetes Center Pilot and Feasibility Proposal (to S. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.